Found: 6
Select item for more details and to access through your institution.
PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway.
- Published in:
- Environmental Toxicology, 2024, v. 39, n. 2, p. 539, doi. 10.1002/tox.23872
- By:
- Publication type:
- Article
An age-and sex-matched postoperative therapy should be required in thyroid papillary carcinoma.
- Published in:
- Frontiers in Endocrinology, 2024, p. 01, doi. 10.3389/fendo.2024.1339191
- By:
- Publication type:
- Article
Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 18, p. 16837, doi. 10.1007/s00432-023-05420-8
- By:
- Publication type:
- Article
CTHRC1 promotes anaplastic thyroid cancer progression by upregulating the proliferation, migration, and invasion of tumor cells.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.15458
- By:
- Publication type:
- Article
Single-Cell RNA Sequencing Revealed a 3-Gene Panel Predicted the Diagnosis and Prognosis of Thyroid Papillary Carcinoma and Associated With Tumor Immune Microenvironment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.862313
- By:
- Publication type:
- Article
Elderly Patients with Nondistant Metastatic Pancreatic Head Adenocarcinoma Cannot Benefit from More Radical Surgery.
- Published in:
- International Journal of Endocrinology, 2022, p. 1, doi. 10.1155/2022/6469740
- By:
- Publication type:
- Article